Impact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS.
Negrín M. Expert Rev Pharmacoecon Outcomes Res. 2018 Sep 6:1-7. Naranjo A, Ojeda-Bruno S, Saavedra A, Molina A, https://www.ncbi.nlm.nih.gov/pubmed/30129375